Aveanna Healthcare Holdings, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $AVAH in the last 30 days.
See all $AVAH insider activity →Aveanna Healthcare (AVAH) will release Q3 results on Nov. 12, 2026, before market open, followed by a conference call at 10 a.m. ET. The call and webcast can be accessed live or replayed later. Aveanna provides healthcare services across 39 states, focusing on pediatric and adult care.
Steven E. Rodgers resigned from Aveanna Healthcare Holdings' Board of Directors, effective October 1, 2026. He also left the Audit and Compensation Committees. The company stated his departure was not due to any disagreements with its operations, policies, or practices. No replacement information was disclosed.
Aveanna Healthcare Holdings, Inc. (AVAH) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 1, 2026, Steven E. Rodgers, a Class II director of Aveanna Healthcare Holdings Inc. (the "Company"), notified th
Over the past 7 days, AlphAI's AI scored 1 news story mentioning AVAH (Aveanna Healthcare Holdings, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent AVAH coverage spans financial news, earnings and corporate actions.
The announcement sets the stage for pre‑market volatility on Nov 12 as investors position ahead of the earnings.
Board resignation may raise governance concerns and could modestly affect stock sentiment.
The resignation may cause slight negative sentiment as investors assess board stability.
Higher target could support price.
Analyst upgrade and higher target could sustain price gains.
AlphAI scores every news story that mentions AVAH with an AI model for sentiment and relevance, and aggregates insider trades from Aveanna Healthcare Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Aveanna Healthcare (AVAH) will release Q3 results on Nov. 12, 2026, before market open, followed by a conference call at 10 a.m. ET. The call and webcast can be accessed live or replayed later. Aveanna provides healthcare services across 39 states, focusing on pediatric and adult care.
1 min readSteven E. Rodgers resigned from Aveanna Healthcare Holdings' Board of Directors, effective October 1, 2026. He also left the Audit and Compensation Committees. The company stated his departure was not due to any disagreements with its operations, policies, or practices. No replacement information was disclosed.
1 min readAveanna Healthcare Holdings, Inc. (AVAH) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 1, 2026, Steven E. Rodgers, a Class II director of Aveanna Healthcare Holdings Inc. (the "Company"), notified th
1 min readJim Cramer recommended buying Energy Transfer LP (NYSE:ET), calling it 'terrific.' Stifel analyst Robert Hodges reinstated ET with a Buy rating and $25 price target. Cramer also discussed other stocks, including SentinelOne, Corning, Gemini Space Station, Aveanna Healthcare, Reformation, and HPE, citing various analyst ratings and price targets.
2 min readInspire Medical Systems (NYSE:INSP), Cybin (NASDAQ:HELP), and Aveanna Healthcare (NASDAQ:AVAH) are flagged as overbought with RSI values above 70. INSP reported strong Q2 results and raised FY26 guidance, while AVAH received an Overweight rating and higher price target from Barclays. All three stocks showed significant gains over the past month.
2 min readInsider trading activity for August 25, 2026, included purchases by executives at TTM Technologies (TTMI), Alpha Metallurgical (AMR), Kura Oncology (KURA), TEAM INC (TISI), and Dorchester Minerals (DMLP). Notable sales occurred at Corpay (CPAY), Aveanna Healthcare (AVAH), Micron Technology (MU), and NLIGHT (LASR). InvestingPro analysis provided fair value assessments for these companies.
3 min readInsider trading activity reported for US public companies includes significant purchases and sales. ADAR1 Capital bought 1.03M Tenax Therapeutics (TENX) shares for $1.81M. Kenneth Courtis acquired 15K Alpha Metallurgical (AMR) shares for $3.16M. Rex Geveden bought 5K TTM Technologies (TTMI) shares for $524.5K. Ashley McEvoy, CEO of Insulet (PODD), purchased 1.1K shares for $162.2K. Notable sales include James Wirth selling IHT shares for $1.82B, Alexander Karp selling 492K Palantir (PLTR) shares
3 min readAveanna Healthcare director Paul R. Vigano-linked entities sold $192.6m in stock. Shares were sold at $11.50 each, and the stock has since risen to $13.70. Aveanna reported Q2 2026 revenue of $670.5m, up 13.7% YoY, and raised its full-year outlook. Raymond James and RBC Capital raised their price targets to $15.00 and $16.00, respectively.
2 min readAveanna Healthcare (AVAH) reported that entities linked to 10% owner Robert M. Williams, Jr. sold 16.75M shares of common stock at $11.50 per share on August 20–21, 2026, in an underwritten secondary offering. The total value of the sales was approximately $146.14M. Williams disclaims beneficial ownership except for his pecuniary interest.
1 min readJ.H. Whitney Equity Partners VII, LLC sold 14,746,077 indirectly-held shares of Aveanna Healthcare Holdings, Inc. (AVAH) at $11.50 ($169.58M total) across 4 trades over 2026-08-20 to 2026-08-21.
1 min read
